BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Spark Therapeutics to Host Conference Call on Tuesday, Nov. 7 at 8:30 a.m. ET to Discuss Third Quarter 2017 Results

  The company will host a conference call on Tuesday, Nov. 7, 2017, at 8:30 a.m. ET.

  October 31, 2017

   · 

  1 min read
• Business

  ObsEva SA to Hold Third Quarter 2017 Financial Results and Business Update Call on November 14, 2017 and Present at Credit Suisse and Jefferies Investor Conferences in November

  Management will host an investment community conference call at 8:00 a.m. ET.

  October 31, 2017

   · 

  2 min read
• Business

  Antares Pharma to Report Third Quarter 2017 Financial and Operating Results and Host Webcast and Conference Call

  Management will host a webcast and conference call at 8:30 a.m. ET on November 7, 2017 to discuss the results.

  October 31, 2017

   · 

  5 min read
• Drug Development

  Akcea and Ionis Report Positive Phase I/IIa Data With AKCEA-APOCIII-LRx

  Akcea expects to initiate Phase 2b in patients with hypertriglyceridemia with established cardiovascular disease by the end of this year.

  October 31, 2017

   · 

  6 min read
• Business

  AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 7, 2017

  Management will host a conference call beginning at 4:30 pm ET that day to review results and provide a corporate update.

  October 31, 2017

   · 

  1 min read
• 

  Drug Development

  Stemline Therapeutics Announces that Pivotal Trial of SL-401 in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Meets Primary Endpoint

  Based on feedback from the FDA, Stemline remains on track to begin submission of its BLA in the 4Q17-1Q18 timeframe.

  October 31, 2017

   · 

  7 min read
• Business

  Melinta and Cempra Name Industry Leader Daniel Wechsler as President and Chief Executive Officer of the Combined Company

  Mr. Wechsler is a seasoned pharma executive with more than 25 years of healthcare experience.

  October 31, 2017

   · 

  14 min read
• Business

  Recro Pharma Reports Inducement Grants for New Staff - Oct. 31, 2017

  The company announced the expansion of its team through the employment of eight new employees in the areas of sales and marketing.

  October 31, 2017

   · 

  4 min read
• Business

  Oxford Immunotec Reports Third Quarter 2017 Financial Results

  Revenue for the third quarter of 2017 was $30.4 million, representing 17% growth over third quarter 2016 revenue of $26.1 million.

  October 31, 2017

   · 

  12 min read
• 

  Drug Development

  Sanofi: Dupilumab Significantly Reduced Steroid Use, Asthma Attacks, and Improved Lung Function in a Phase III Study of People With Severe Steroid-Dependent Asthma

  Dupilumab added to standard therapies significantly reduced the use of maintenance oral corticosteroids (OCS) by 70% on average.

  October 31, 2017

   · 

  18 min read